Current state of clinical trials in Korea

Journal of the Korean Medical Association

Volumn 53, Issue 9, 2010, Pages 745-752

  Han, Seunghoon ^a   Yim, Dong Seok ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Clinical trial; KFDA; KoNECT; Korea

Indexed keywords

EID: 77957299208     PISSN: 19758456     EISSN: None     Source Type: Journal    
DOI: 10.5124/jkma.2010.53.9.745     Document Type: Article

References (16)

1. Karlberg J. Industry Sponsored Clinical Trials in South Korea. Clin Trial Magnifier 2008; 1:179-192.
2. KFDA Press release; Jul 20, 2010.
3. IMS Press release, IMS Forecasts Global Pharmaceutical Market Growth of 5-8% Annually through 2014; Maintains Expectations of 4-6% Growth in 2010; Apr 20, 2010.
4. IMS Press release, IMS Forecasts Global Pharmaceutical Market Growth of 4-6% in 2010; Predicts 4-7% Expansion Through 2013; Oct 07, 2009.
5. KFDA Press release; Jun 10, 2010.
6. Yoon SH, Moon JE, Oh SJ, Choi JH, Kim YI. Research Development Status of Biosimilar Drugs. J Cosmet Public Health 2009; 5:108-113.
7. KFDA Press release; Feb 9, 2010.
8. The Hub of Clinical Trial. The Korean Hospital News; Jul 8, 2010.
9. MOWH Press release; Jul 26, 2010.
10. Accredited Clinical Trial Institutions, KFDA; Jun 24, 2010.
11. FERCAP-SIDCER Recognized ECs/IRBs. Available from: http://www.fercap- sidcer.org/recognizedphp
12. AAHRPP accredited organizations. Available from: http://www.aahrpp.ora/ www.aspx?PageID=11&Country=KR#grid
13. Kim DY, Kwon OD, Kim SG, Shin IH. Recognitional study about patients and caregivers' understanding of clinical trial. J Korean Continence Soc 2008; 12: 48-57.
14. Moon H, Kim HK, Lee KS, Kang BK, Song HH. A Survey of the Cognition on Clinical Trial and Informed Consent of Cancer Patients and Their Families. Korean J Clin Pharmacol Ther 1995; 3:141-150.
15. World health statistics 2010, World Health Organization. Available from: http://wwwwho.int/whosis/whostat/2010.
16. Mathieu M. Strategy Report to Enhance Korea's Global Competitiveness Through the Detailed and Professional Analysis of Global and Asia. Clinical Trial Environments p. 57-64.